By Counterforce Health Team in Pomalyst (pomalidomide) —

How to Get Pomalyst (Pomalidomide) Covered by Humana in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pomalyst Covered by Humana in California

Pomalyst (pomalidomide) requires prior authorization from Humana in California. The fastest path to approval involves three key steps: (1) Ensure your oncologist documents prior failure of both lenalidomide and a proteasome inhibitor, (2) Complete REMS program enrollment for prescriber, patient, and pharmacy, and (3) Submit the prior authorization through Humana's provider portal or fax to 877-486-2621. If denied, California's Independent Medical Review (IMR) offers binding external appeals with high success rates for specialty cancer drugs. Start by confirming your plan type and gathering treatment records today.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Verify Your Coverage
  3. Gather What You Need
  4. Submit the Prior Authorization Request
  5. Follow-Up and Tracking
  6. Typical Timelines in California
  7. If You're Asked for More Information
  8. If Your Request is Denied
  9. California's Independent Medical Review (IMR)
  10. Renewal and Re-Authorization
  11. Costs and Financial Assistance
  12. Quick Reference Checklist
  13. Frequently Asked Questions

What This Guide Covers

This guide helps patients with multiple myeloma and their healthcare teams navigate Humana's prior authorization process for Pomalyst (pomalidomide) in California. Whether you're facing an initial request or appealing a denial, you'll find step-by-step instructions, required forms, and California-specific appeal rights.

Who this helps:

  • Patients with relapsed/refractory multiple myeloma prescribed Pomalyst
  • Oncologists and hematologists submitting prior authorizations
  • Caregivers advocating for coverage approval
  • Anyone appealing a Humana denial in California

Before You Start: Verify Your Coverage

Confirm Your Plan Type

Check your Humana plan details:

  • Most Humana members in California have Medicare Advantage plans
  • Verify if you have Part D prescription coverage
  • Log into your Humana member portal to confirm formulary status

Formulary and Tier Information

Pomalyst typically appears on Humana's specialty tier with prior authorization requirements. The medication requires:

  • Prior authorization (always required)
  • Specialty pharmacy dispensing through REMS-certified facilities
  • Step therapy documentation showing prior lenalidomide and proteasome inhibitor failure
Note: New Humana members actively taking Pomalyst may receive temporary coverage for the first 90 days while prior authorization is processed.

Gather What You Need

Essential Documentation Checklist

Medical Records:

  • ✅ Multiple myeloma diagnosis with ICD-10 code C90.00
  • ✅ Pathology reports confirming diagnosis
  • ✅ Treatment timeline showing progression within 60 days of last therapy
  • ✅ Documentation of prior lenalidomide (Revlimid) failure or intolerance
  • ✅ Documentation of prior proteasome inhibitor failure (bortezomib, carfilzomib, etc.)
  • ✅ Recent labs and imaging showing disease status

Regulatory Requirements:

  • ✅ REMS program enrollment confirmation for prescriber
  • ✅ REMS program enrollment for patient
  • ✅ REMS-certified specialty pharmacy identification
  • ✅ Pregnancy testing documentation (if applicable)

Prescriber Information:

  • ✅ Oncologist or hematologist credentials
  • ✅ Medical necessity letter addressing FDA-approved indications
  • ✅ Dosing plan (typically 4mg daily, days 1-21 of 28-day cycles)
  • ✅ Combination therapy plan with dexamethasone

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Always required Humana PA portal Humana Policy
Specialist Prescriber Oncologist/hematologist only Provider credentials PA Form
Prior Therapy Failed lenalidomide + proteasome inhibitor Treatment records FDA Label
REMS Enrollment Mandatory safety program Manufacturer website FDA Requirement
Specialty Pharmacy REMS-certified only Pharmacy certification REMS Program
Appeal Deadline 65 days from denial Denial letter CMS Regulation

Submit the Prior Authorization Request

Step-by-Step Submission Process

1. Access Humana's Prior Authorization System

2. Complete Required Forms Your oncologist must submit:

  • Humana Medicare Part D prior authorization form
  • Medical necessity letter
  • Supporting clinical documentation
  • REMS enrollment verification

3. Include Point-by-Point Clinical Justification Address these specific criteria in your medical necessity letter:

  • FDA-approved indication for relapsed/refractory multiple myeloma
  • Prior therapy with lenalidomide and proteasome inhibitor
  • Disease progression within 60 days of last treatment
  • Patient meets NCCN guidelines for pomalidomide therapy
  • Contraindications to alternative therapies (if applicable)
Tip: Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements.

Follow-Up and Tracking

Monitoring Your Request

Timeline expectations:

  • Standard review: 72 hours to 7 days for most specialty drugs
  • Complex cases: Up to 14 days for complete file review
  • Expedited review: 24 hours if urgent medical need documented

Sample Follow-Up Script

"I'm calling to check the status of a prior authorization request for Pomalyst submitted on [date]. The patient's name is [name], member ID [number], and the reference number is [number]. Can you provide the current status and expected decision date?"

Document each call:

  • Date and time
  • Representative name
  • Reference numbers provided
  • Next steps or additional information requested

Typical Timelines in California

Humana Medicare Processing Times

Initial Prior Authorization:

  • Standard request: 3-7 business days
  • Expedited request: 24-72 hours (requires medical urgency documentation)
  • Complex cases requiring additional review: Up to 14 days

California-Specific Protections:

  • Humana must provide written determination within regulatory timeframes
  • Expedited appeals available for urgent situations
  • Independent Medical Review (IMR) provides final binding decision

If You're Asked for More Information

Common Information Requests

Medical Necessity Clarification:

  • Updated treatment response documentation
  • Recent imaging or lab results
  • Detailed prior therapy timeline with specific dates
  • Contraindication documentation for alternative therapies

REMS Compliance Verification:

  • Prescriber REMS certification status
  • Patient REMS enrollment confirmation
  • Pharmacy REMS certification
  • Pregnancy testing compliance (if applicable)

Responding Effectively

Submit additional information within the timeframe specified (typically 14 days). Include:

  • Cover letter referencing the original PA request
  • All requested documentation
  • Updated medical necessity letter if clinical status has changed

If Your Request is Denied

Common Denial Reasons and Fixes

Denial Reason How to Fix Required Documentation
Prior therapy not documented Submit complete treatment timeline Pharmacy records, oncology notes
REMS enrollment incomplete Complete all REMS requirements Certification confirmations
Non-specialist prescriber Transfer to oncologist/hematologist Specialist referral and prescription
Medical necessity not established Strengthen clinical justification Updated medical necessity letter
Step therapy not completed Document contraindications to alternatives Clinical notes, allergy history

Internal Appeal Process

Timeline: Must appeal within 65 days of denial notice

Required submissions:

  • Original denial letter
  • Updated medical necessity letter addressing denial reasons
  • Additional clinical documentation
  • Peer-reviewed literature supporting use (if applicable)

Submission methods:

  • Online through Humana member portal
  • Fax to appeals department
  • Mail to address provided in denial letter
From our advocates: We've seen successful appeals when oncologists include specific dates of lenalidomide failure and disease progression, along with NCCN guideline citations. One patient received approval after the appeal included pharmacy records showing exact dates of prior therapy and documented side effects leading to discontinuation.

California's Independent Medical Review (IMR)

When Internal Appeals Fail

If Humana upholds the denial after internal appeal, California members can request an Independent Medical Review through the Department of Managed Health Care (DMHC).

Key advantages of California's IMR:

  • Binding decision that Humana must follow
  • No cost to the patient
  • Independent clinical experts review the case
  • High success rates for specialty cancer drugs

IMR Timeline and Process

Standard IMR: Decision within 45 days Expedited IMR: Decision within 7 days for urgent cases

How to request IMR:

  1. Complete internal appeal with Humana first
  2. Apply online at healthhelp.ca.gov
  3. Call DMHC Help Center: 888-466-2219
  4. Submit all medical records and denial correspondence

Required documentation:

  • Humana's final internal appeal denial
  • Complete medical records
  • Treating physician's statement of medical necessity
  • Any relevant clinical studies or guidelines

California's IMR system has demonstrated high success rates for specialty drug appeals, particularly for rare disease and oncology medications where medical necessity is well-documented.

Renewal and Re-Authorization

Planning for Continued Coverage

Typical authorization periods:

  • Initial approval: 6-12 months
  • Renewal requirements: Evidence of continued medical necessity

Renewal documentation:

  • Updated oncology notes showing treatment response
  • Recent labs and imaging
  • Confirmation of continued REMS compliance
  • Documentation that patient tolerates therapy without significant adverse effects

Timeline for renewal:

  • Submit renewal request 30-45 days before current authorization expires
  • Allow additional time during year-end formulary changes

Costs and Financial Assistance

Understanding Your Costs

Pomalyst retail costs approximately $23,400 for a 21-day supply. Your actual cost depends on:

  • Humana plan's specialty tier copay or coinsurance
  • Whether you've met your annual deductible
  • Medicare Part D coverage gap ("donut hole") status

Financial Assistance Options

Bristol Myers Squibb Access Support:

  • Benefits verification and prior authorization assistance
  • Copay assistance programs for eligible patients
  • Patient assistance programs for uninsured/underinsured
  • Free drug programs based on financial need

Additional Resources:

  • Medicare Extra Help program for low-income beneficiaries
  • State pharmaceutical assistance programs
  • Cancer-specific foundations and grants

Note: Pomalyst is included in Medicare's 2025 drug price negotiation program, with new prices expected to take effect in 2027.

Quick Reference Checklist

Before Submitting PA Request

  • Confirm Humana plan type and formulary status
  • Gather complete prior therapy documentation
  • Ensure REMS enrollment for all parties
  • Obtain specialist prescription from oncologist/hematologist

During PA Review

  • Track submission with reference number
  • Follow up within expected timeline
  • Respond promptly to information requests
  • Document all communications

If Denied

  • Review denial letter for specific reasons
  • File internal appeal within 65 days
  • Gather additional supporting documentation
  • Consider peer-to-peer review request
  • Prepare for California IMR if needed

Frequently Asked Questions

Q: How long does Humana prior authorization take for Pomalyst in California? A: Standard requests typically take 3-7 business days, while expedited requests for urgent medical situations are decided within 24-72 hours.

Q: What if Pomalyst isn't on Humana's formulary? A: You can request a formulary exception through the prior authorization process. California's IMR system can review formulary exception denials.

Q: Can I get expedited appeals in California? A: Yes, both Humana's internal expedited appeals (72 hours) and California's expedited IMR (7 days) are available for urgent medical situations.

Q: Does step therapy apply if I failed these drugs with a different insurer? A: Documentation of prior therapy failure from any provider should satisfy step therapy requirements. Include pharmacy records and clinical notes from previous treatment.

Q: What happens if I'm already taking Pomalyst when I switch to Humana? A: New Humana members may receive temporary coverage for up to 90 days while the prior authorization is processed, but you must provide evidence of active treatment.

Q: Who can prescribe Pomalyst for Humana coverage? A: Only oncologists or hematologists can prescribe Pomalyst for Humana coverage. Primary care physicians cannot obtain prior authorization approval.

Q: How often do I need to renew prior authorization? A: Initial authorizations typically last 6-12 months. Renewal requires updated documentation showing continued medical necessity and treatment response.

Q: What if my appeal is denied by Humana? A: California residents can request an Independent Medical Review (IMR) through the DMHC, which provides a binding external review by independent clinical experts.

For patients and providers navigating complex prior authorization requirements, Counterforce Health offers specialized support in turning insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with each payer's specific requirements, helping patients access critical medications like Pomalyst more efficiently.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Coverage policies and procedures may change; verify current requirements with Humana and California regulatory agencies.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.